 | • レポートコード：D005-13092 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、放射性医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。放射性医薬品の種類別市場規模（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他）、用途別市場規模（腫瘍学、循環器学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）： ・地域別グローバル市場分析 2015年-2020年 ・放射性医薬品の北米市場（アメリカ、カナダ、メキシコ） ・放射性医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・放射性医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・放射性医薬品の南米市場（ブラジル、アルゼンチン） ・放射性医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他 ・用途別分析：腫瘍学、循環器学、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Summary
Market Overview
The global Radiopharmaceutical market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.2% in the forecast period of 2020 to 2025 and will expected to reach USD 8281 million by 2025, from USD 6035.2 million in 2019.
The Radiopharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Radiopharmaceutical market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Radiopharmaceutical market has been segmented into Actinium-225, Lutetium-177, Radium-223, Holmium-166, Other, etc.
By Application, Radiopharmaceutical has been segmented into Oncology, Cardiology, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radiopharmaceutical market presented in the report. This section sheds light on the sales growth of different regional and country-level Radiopharmaceutical markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radiopharmaceutical market.
The report offers in-depth assessment of the growth and other aspects of the Radiopharmaceutical market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Radiopharmaceutical markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Radiopharmaceutical Market Share Analysis
Radiopharmaceutical competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Radiopharmaceutical sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radiopharmaceutical sales, revenue and market share for each player covered in this report.
The major players covered in Radiopharmaceutical are: Bracco Imaging, GE Healthcare, Nordion, Bayer, IBA Group, Mallinckrodt, Jubilant Pharma, Lantheus, Triad Isotopes, China Isotope & Radiation, Navidea, Eli Lilly, Dongcheng, Advanced Accelerator Applications, SIEMENS, etc. Among other players domestic and global, Radiopharmaceutical market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales, revenue and global market share of Radiopharmaceutical in 2018 and 2019.
Chapter 3, the Radiopharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceutical Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceutical Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Overview of Global Radiopharmaceutical Market
1.4.1 Global Radiopharmaceutical Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bracco Imaging SWOT Analysis
2.1.4 Bracco Imaging Product and Services
2.1.5 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GE Healthcare SWOT Analysis
2.2.4 GE Healthcare Product and Services
2.2.5 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nordion
2.3.1 Nordion Details
2.3.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nordion SWOT Analysis
2.3.4 Nordion Product and Services
2.3.5 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 IBA Group
2.5.1 IBA Group Details
2.5.2 IBA Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 IBA Group SWOT Analysis
2.5.4 IBA Group Product and Services
2.5.5 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mallinckrodt SWOT Analysis
2.6.4 Mallinckrodt Product and Services
2.6.5 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Jubilant Pharma
2.7.1 Jubilant Pharma Details
2.7.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Jubilant Pharma SWOT Analysis
2.7.4 Jubilant Pharma Product and Services
2.7.5 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lantheus SWOT Analysis
2.8.4 Lantheus Product and Services
2.8.5 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Triad Isotopes
2.9.1 Triad Isotopes Details
2.9.2 Triad Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Triad Isotopes SWOT Analysis
2.9.4 Triad Isotopes Product and Services
2.9.5 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 China Isotope & Radiation
2.10.1 China Isotope & Radiation Details
2.10.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 China Isotope & Radiation SWOT Analysis
2.10.4 China Isotope & Radiation Product and Services
2.10.5 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Navidea
2.11.1 Navidea Details
2.11.2 Navidea Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Navidea SWOT Analysis
2.11.4 Navidea Product and Services
2.11.5 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eli Lilly SWOT Analysis
2.12.4 Eli Lilly Product and Services
2.12.5 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Dongcheng
2.13.1 Dongcheng Details
2.13.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Dongcheng SWOT Analysis
2.13.4 Dongcheng Product and Services
2.13.5 Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Advanced Accelerator Applications
2.14.1 Advanced Accelerator Applications Details
2.14.2 Advanced Accelerator Applications Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Advanced Accelerator Applications SWOT Analysis
2.14.4 Advanced Accelerator Applications Product and Services
2.14.5 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 SIEMENS
2.15.1 SIEMENS Details
2.15.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 SIEMENS SWOT Analysis
2.15.4 SIEMENS Product and Services
2.15.5 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceutical Manufacturer Market Share in 2019
3.3.2 Top 6 Radiopharmaceutical Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceutical Sales and Market Share by Regions (2015-2020)
4.1.2 Global Radiopharmaceutical Revenue and Market Share by Regions (2015-2020)
4.2 North America Radiopharmaceutical Sales and Growth Rate (2015-2020)
4.3 Europe Radiopharmaceutical Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Radiopharmaceutical Sales and Growth Rate (2015-2020)
4.5 South America Radiopharmaceutical Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Country
5.1.1 North America Radiopharmaceutical Sales and Market Share by Country (2015-2020)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
5.2 United States Radiopharmaceutical Sales and Growth Rate (2015-2020)
5.3 Canada Radiopharmaceutical Sales and Growth Rate (2015-2020)
5.4 Mexico Radiopharmaceutical Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Country
6.1.1 Europe Radiopharmaceutical Sales and Market Share by Country (2015-2020)
6.1.2 Europe Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
6.2 Germany Radiopharmaceutical Sales and Growth Rate (2015-2020)
6.3 UK Radiopharmaceutical Sales and Growth Rate (2015-2020)
6.4 France Radiopharmaceutical Sales and Growth Rate (2015-2020)
6.5 Russia Radiopharmaceutical Sales and Growth Rate (2015-2020)
6.6 Italy Radiopharmaceutical Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Radiopharmaceutical Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Radiopharmaceutical Revenue and Market Share by Regions (2015-2020)
7.2 China Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.3 Japan Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.4 Korea Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.5 India Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.7 Australia Radiopharmaceutical Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Country
8.1.1 South America Radiopharmaceutical Sales and Market Share by Country (2015-2020)
8.1.2 South America Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
8.2 Brazil Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.3 Argentina Radiopharmaceutical Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Radiopharmaceutical Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Radiopharmaceutical Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.3 Turkey Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.4 Egypt Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.5 South Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Radiopharmaceutical Sales and Market Share by Type (2015-2020)
10.2 Global Radiopharmaceutical Revenue and Market Share by Type (2015-2020)
10.3 Global Radiopharmaceutical Price by Type (2015-2020)
11 Global Radiopharmaceutical Market Segment by Application
11.1 Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
11.2 Global Radiopharmaceutical Revenue Market Share by Application (2015-2020)
11.3 Global Radiopharmaceutical Price by Application (2015-2020)
12 Market Forecast
12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2021-2025)
12.2 Radiopharmaceutical Market Forecast by Regions (2021-2025)
12.2.1 North America Radiopharmaceutical Market Forecast (2021-2025)
12.2.2 Europe Radiopharmaceutical Market Forecast (2021-2025)
12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2021-2025)
12.2.4 South America Radiopharmaceutical Market Forecast (2021-2025)
12.2.5 Middle East & Africa Radiopharmaceutical Market Forecast (2021-2025)
12.3 Radiopharmaceutical Market Forecast by Type (2021-2025)
12.3.1 Global Radiopharmaceutical Sales Forecast by Type (2021-2025)
12.3.2 Global Radiopharmaceutical Market Share Forecast by Type (2021-2025)
12.4 Radiopharmaceutical Market Forecast by Application (2021-2025)
12.4.1 Global Radiopharmaceutical Sales Forecast by Application (2021-2025)
12.4.2 Global Radiopharmaceutical Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Radiopharmaceutical Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Radiopharmaceutical Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 8. Bracco Imaging Radiopharmaceutical Major Business
Table 9. Bracco Imaging Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 10. Bracco Imaging SWOT Analysis
Table 11. Bracco Imaging Radiopharmaceutical Product and Services
Table 12. Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 14. GE Healthcare Radiopharmaceutical Major Business
Table 15. GE Healthcare Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 16. GE Healthcare SWOT Analysis
Table 17. GE Healthcare Radiopharmaceutical Product and Services
Table 18. GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Nordion Basic Information, Manufacturing Base and Competitors
Table 20. Nordion Radiopharmaceutical Major Business
Table 21. Nordion Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 22. Nordion SWOT Analysis
Table 23. Nordion Radiopharmaceutical Product and Services
Table 24. Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer Basic Information, Manufacturing Base and Competitors
Table 26. Bayer Radiopharmaceutical Major Business
Table 27. Bayer Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 28. Bayer SWOT Analysis
Table 29. Bayer Radiopharmaceutical Product and Services
Table 30. Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. IBA Group Basic Information, Manufacturing Base and Competitors
Table 32. IBA Group Radiopharmaceutical Major Business
Table 33. IBA Group Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 34. IBA Group SWOT Analysis
Table 35. IBA Group Radiopharmaceutical Product and Services
Table 36. IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 38. Mallinckrodt Radiopharmaceutical Major Business
Table 39. Mallinckrodt Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 40. Mallinckrodt SWOT Analysis
Table 41. Mallinckrodt Radiopharmaceutical Product and Services
Table 42. Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Jubilant Pharma Radiopharmaceutical Major Business
Table 45. Jubilant Pharma Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 46. Jubilant Pharma SWOT Analysis
Table 47. Jubilant Pharma Radiopharmaceutical Product and Services
Table 48. Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Lantheus Basic Information, Manufacturing Base and Competitors
Table 50. Lantheus Radiopharmaceutical Major Business
Table 51. Lantheus Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 52. Lantheus SWOT Analysis
Table 53. Lantheus Radiopharmaceutical Product and Services
Table 54. Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 56. Triad Isotopes Radiopharmaceutical Major Business
Table 57. Triad Isotopes Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 58. Triad Isotopes SWOT Analysis
Table 59. Triad Isotopes Radiopharmaceutical Product and Services
Table 60. Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 62. China Isotope & Radiation Radiopharmaceutical Major Business
Table 63. China Isotope & Radiation Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 64. China Isotope & Radiation SWOT Analysis
Table 65. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 66. China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Navidea Basic Information, Manufacturing Base and Competitors
Table 68. Navidea Radiopharmaceutical Major Business
Table 69. Navidea Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 70. Navidea SWOT Analysis
Table 71. Navidea Radiopharmaceutical Product and Services
Table 72. Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Radiopharmaceutical Major Business
Table 75. Eli Lilly Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 76. Eli Lilly SWOT Analysis
Table 77. Eli Lilly Radiopharmaceutical Product and Services
Table 78. Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 80. Dongcheng Radiopharmaceutical Major Business
Table 81. Dongcheng Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 82. Dongcheng SWOT Analysis
Table 83. Dongcheng Radiopharmaceutical Product and Services
Table 84. Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 86. Advanced Accelerator Applications Radiopharmaceutical Major Business
Table 87. Advanced Accelerator Applications Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 88. Advanced Accelerator Applications SWOT Analysis
Table 89. Advanced Accelerator Applications Radiopharmaceutical Product and Services
Table 90. Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 92. SIEMENS Radiopharmaceutical Major Business
Table 93. SIEMENS Radiopharmaceutical Total Revenue (USD Million) (2017-2018)
Table 94. SIEMENS SWOT Analysis
Table 95. SIEMENS Radiopharmaceutical Product and Services
Table 96. SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Radiopharmaceutical Sales by Manufacturer (2018-2019) (M Doses)
Table 98. Global Radiopharmaceutical Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Radiopharmaceutical Sales by Regions (2015-2020) (M Doses)
Table 100. Global Radiopharmaceutical Sales Market Share by Regions (2015-2020)
Table 101. Global Radiopharmaceutical Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 103. North America Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 104. North America Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 106. Europe Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 107. Europe Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 108. Europe Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Radiopharmaceutical Sales by Regions (2015-2020) (M Doses)
Table 110. Asia-Pacific Radiopharmaceutical Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Radiopharmaceutical Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 113. South America Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 114. South America Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 117. Middle East & Africa Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 120. Global Radiopharmaceutical Sales by Type (2015-2020) (M Doses)
Table 121. Global Radiopharmaceutical Sales Share by Type (2015-2020)
Table 122. Global Radiopharmaceutical Revenue by Type (2015-2020) (USD Million)
Table 123. Global Radiopharmaceutical Revenue Share by Type (2015-2020)
Table 124. Global Radiopharmaceutical Sales by Application (2015-2020) (M Doses)
Table 125. Global Radiopharmaceutical Sales Share by Application (2015-2020)
Table 126. Global Radiopharmaceutical Sales Forecast by Regions (2021-2025) (M Doses)
Table 127. Global Radiopharmaceutical Market Share Forecast by Regions (2021-2025)
Table 128. Global Radiopharmaceutical Sales Forecast by Type (2021-2025) (M Doses)
Table 129. Global Radiopharmaceutical Market Share Forecast by Type (2021-2025)
Table 130. Global Radiopharmaceutical Sales Forecast by Application (2021-2025)
Table 131. Global Radiopharmaceutical Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Radiopharmaceutical Picture
Figure 2. Global Sales Market Share of Radiopharmaceutical by Type in 2019
Figure 3. Actinium-225 Picture
Figure 4. Lutetium-177 Picture
Figure 5. Radium-223 Picture
Figure 6. Holmium-166 Picture
Figure 7. Other Picture
Figure 8. Radiopharmaceutical Sales Market Share by Application in 2018
Figure 9. Oncology Picture
Figure 10. Cardiology Picture
Figure 11. Other Picture
Figure 12. Global Radiopharmaceutical Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Radiopharmaceutical Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Radiopharmaceutical Sales Market Share by Manufacturer in 2019
Figure 33. Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Radiopharmaceutical Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 38. Global Radiopharmaceutical Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Radiopharmaceutical Revenue Market Share by Regions (2015-2020)
Figure 40. Global Radiopharmaceutical Revenue Market Share by Regions in 2018
Figure 41. North America Radiopharmaceutical Sales and Growth Rate (2015-2020)
Figure 42. Europe Radiopharmaceutical Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Radiopharmaceutical Sales and Growth Rate (2015-2020)
Figure 44. South America Radiopharmaceutical Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)
Figure 46. North America Radiopharmaceutical Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Figure 48. North America Radiopharmaceutical Sales Market Share by Countries in 2018
Figure 49. North America Radiopharmaceutical Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Radiopharmaceutical Revenue Market Share by Countries in 2018
Figure 51. United States Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 52. Canada Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 53. Mexico Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 54. Europe Radiopharmaceutical Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Radiopharmaceutical Revenue Market Share by Countries in 2019
Figure 57. Germany Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 58. UK Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 59. France Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 60. Russia Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 61. Italy Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 62. Asia-Pacific Radiopharmaceutical Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Radiopharmaceutical Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Radiopharmaceutical Revenue Market Share by Regions 2019
Figure 65. China Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 66. Japan Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 67. Korea Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 68. India Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 69. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 70. South America Radiopharmaceutical Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Radiopharmaceutical Sales Market Share by Countries in 2019
Figure 72. South America Radiopharmaceutical Revenue Market Share by Countries in 2019
Figure 73. Brazil Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 74. Argentina Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 75. Middle East and Africa Radiopharmaceutical Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Radiopharmaceutical Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Radiopharmaceutical Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 80. Egypt Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 81. Turkey Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 82. South Africa Radiopharmaceutical Sales and Growth Rate (2015-2020) (M Doses)
Figure 83. Global Radiopharmaceutical Sales and Growth Rate (2021-2025) (M Doses)
Figure 84. Global Radiopharmaceutical Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Radiopharmaceutical Market Forecast (2021-2025) (M Doses)
Figure 86. Europe Sales Radiopharmaceutical Market Forecast (2021-2025) (M Doses)
Figure 87. Asia-Pacific Sales Radiopharmaceutical Market Forecast (2021-2025) (M Doses)
Figure 88. South America Sales Radiopharmaceutical Market Forecast (2021-2025) (M Doses)
Figure 89. Middle East & Africa Sales Radiopharmaceutical Market Forecast (2021-2025) (M Doses)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
酸化ホルミウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Holmium Oxide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Holmium Oxide market report pro…- ホルミウムレーザー砕石装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Holmium Laser Lithotripsy Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Holmium Las…
- 循環器外科及びインターベンショナル循環器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cardiology Surgical & Interventional Cardiology Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in…
- リファビッシュ循環器・心臓病用機器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Refurbished Cardiovascular and Cardiology Equipment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 介入性心臓病学および周辺血管装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Interventional Cardiology & Peripheral Vascular Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in…